Doctors test using hepatitis C-Positive hearts to save lives on transplant waitlist
NCT ID NCT03222531
Summary
This study is testing whether hearts from donors who have hepatitis C can be safely transplanted into patients who do not have the virus. The goal is to expand the pool of available donor hearts for people with severe heart failure. After transplant, patients receive antiviral medication to try to prevent or treat any hepatitis C infection that might be transmitted from the donor.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEART TRANSPLANT are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
UPMC
Pittsburgh, Pennsylvania, 15213, United States
Conditions
Explore the condition pages connected to this study.